branchenspezifische Dividenden GlaxoSmithKline Pharmaceuticals Limited
Aktien
946008
INE159A01016
GLAXO
Pharmazeutika
Markt geschlossen -
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
2.855,35 INR | +1,33 % | +0,87 % | +50,49 % |
05.08. | Transcript : GlaxoSmithKline Pharmaceuticals Limited - Shareholder/Analyst Call | |
02.08. | GlaxoSmithKline Pharmaceuticals Limited meldet Ergebnis für das erste Quartal bis zum 30. Juni 2024 | CI |
Zu einer Liste hinzufügen 0 ausgewählt | Dividendenrendite (Y) | Dividendenrendite (Y+1) | KGV | Price to Book | EV / Sales | Marktkap. / EBITDA | Marktkap. / EBIT | Kap. ($) | |
---|---|---|---|---|---|---|---|---|---|
+1,08% | +1,17% | 56.13x | 24,38 | - | - | - | 5,68 Mrd. | ||
+0,58% | +0,67% | 58.11x | 40,04 | 18.01x | 43.74x | 47.49x | 812 Mrd. | ||
+1,30% | +1,72% | 38.54x | 27,01 | 13.43x | 27.34x | 30.34x | 573 Mrd. | ||
+2,80% | +3,07% | 21.43x | 5,704 | 4.63x | 13.14x | 14.87x | 403 Mrd. | ||
+3,13% | +3,24% | 38.8x | 42,14 | 7.32x | 15.82x | 16.4x | 352 Mrd. | ||
+2,67% | +2,80% | 15.38x | 5,957 | 4.89x | 11.2x | 12.66x | 292 Mrd. | ||
+1,91% | +2,02% | 28.97x | 5,972 | 5.21x | 15.46x | 16.06x | 251 Mrd. | ||
+3,66% | +3,76% | 16.05x | 5,952 | 3.81x | 9.97x | 11.07x | 255 Mrd. | ||
+3,24% | +3,35% | 21.08x | 5,292 | 4.99x | 12.63x | 13.31x | 236 Mrd. | ||
+2,79% | +3,01% | 50.67x | 35,23 | 6.84x | 11.97x | 15.27x | 177 Mrd. | ||
+5,60% | +5,71% | 21.83x | 1,922 | 3.73x | 10.2x | 12.24x | 169 Mrd. | ||
+3,64% | +3,85% | 20.07x | 1,730 | 2.97x | 10.26x | 11.2x | 146 Mrd. | ||
+3,78% | +3,97% | 302.53x | 5,150 | 4.28x | 11.76x | 15.99x | 101 Mrd. | ||
+4,85% | +5,09% | -24.98x | 5,312 | 2.96x | 25.81x | 30.38x | 99,91 Mrd. | ||
+3,61% | +3,83% | 13.2x | 4,312 | 2.53x | 7.51x | 8.69x | 89,02 Mrd. | ||
+1,14% | +1,39% | 46.67x | 5,974 | 5.08x | 29.29x | 38.29x | 70,32 Mrd. | ||
+1,32% | +1,38% | 29.75x | 5,874 | 8.94x | 18.83x | 20.16x | 75,98 Mrd. | ||
+4,59% | +4,71% | 59.98x | 0,9285 | 2.45x | 10.26x | 36.79x | 47,43 Mrd. | ||
+1,62% | +1,82% | 24.95x | 2,121 | 3.81x | 15.11x | 16.96x | 47,03 Mrd. | ||
Durchschnitt | +2,81 % | +2,98 % | 44,17x | 12,16 | 5,88x | 16,68x | 20,45x | 221,21 Mrd. | |
Gewichteter Durchschnitt nach Marktkapitalisierung | +2,39 % | +2,57 % | 39,78x | 19,16 | 8,63x | 21,25x | 23,82x |
- Börse
- Aktien
- 946008 Aktie
- Sektor GlaxoSmithKline Pharmaceuticals Limited
- branchenspezifische Dividenden
MarketScreener is also available in this country: United States.
Switch edition